Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials

IF 12.8 1区医学 Q1 HEMATOLOGY

Leukemia Pub Date : 2024-09-25 DOI:10.1038/s41375-024-02420-6

Georg Lenz, Hervé Tilly, Marita Ziepert, Bettina Altmann, Charles Herbaux, Fabian Frontzek, Maike Nickelsen, Calvin Lee, Jamie Hirata, Deniz Sahin, Saibah Chohan, Connie Lee Batlevi, Mark Yan, Franck Morschhauser, Norbert Schmitz

引用次数: 0

Abstract Image

查看原文本刊更多论文

Pola-R-CHP或R-CHOEP用于年轻高危弥漫大B细胞淋巴瘤患者的一线治疗：两项随机三期试验的回顾性比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia 医学-血液学

CiteScore

18.10

自引率

3.50%

发文量

270

审稿时长

3-6 weeks

期刊介绍： Title: Leukemia Journal Overview: Publishes high-quality, peer-reviewed research Covers all aspects of research and treatment of leukemia and allied diseases Includes studies of normal hemopoiesis due to comparative relevance Topics of Interest: Oncogenes Growth factors Stem cells Leukemia genomics Cell cycle Signal transduction Molecular targets for therapy And more Content Types: Original research articles Reviews Letters Correspondence Comments elaborating on significant advances and covering topical issues